Kurin Inc., the inventor and manufacturer of 510(k)-cleared Kurin® blood culture collection sets, has received a second 510(k) clearance (K181895) for its new Kurin® PIV18 peripheral IV configuration with an extension set, which can be used for infusion.
Kurin, Inc., the inventor and manufacturer of 510(k)-cleared Kurin® blood culture collection sets, announced today that the Temple VA Hospital in Temple, TX, presented their findings comparing results of Kurin and Magnolia Medical’s Steripath at the recent Southwest Association of Clinical Microbiology.
Spinal Singularity announced that the company was awarded a Phase II SBIR grant from the National Institute of Health (NIH). The grant will provide approximately $1.5 Million in non-dilutive funding to continue clinical development of the Connected Catheter 2P (C2P).
Spinal Singularity announced that the first patient has been treated with the Connected Catheter, an innovative, smart catheter system designed for adult males with Chronic Urinary Retention and/or Neurogenic Lower Urinary Tract Dysfunction (NLUTD).
StimGuard yesterday announced plans for a clinical trial comparing its nerve stimulator with the InterStim sacral nerve stimulator made by Medtronic (NYSE:MDT).
Spinal Singularity, a San Clemente, CA-based developer of a connected catheter, closed a $3.1M in equity funding.
Dr. Robert Eastlack is honored again as one of the top spine surgeons in San Diego.
